On the other hand, 120h exposure to the CMDV and later to the Tyr kinase inhibitor imatinib do not restore endothelial integrity, suggesting that the endothelial dysfunction induced by the CMDV is relatively insensitive to the targets of imatinib, e.g., c-ABL. Here, ABL1 is linked to endothelial dysfunction.